{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:14:54Z","timestamp":1762521294175},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1097\/rhu.0b013e31816b1931","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T14:12:37Z","timestamp":1236262357000},"page":"153-155","source":"Crossref","is-referenced-by-count":10,"title":["Prevention, Diagnosis, and Treatment of Glucocorticoid Induced Osteoporosis by Rheumatologists in a Latin-American City"],"prefix":"10.1097","volume":"14","author":[{"given":"Carlo V.","family":"Caballero-Uribe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan G.","family":"Acosta-Velez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eder A.","family":"Hernandez-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando M.","family":"Andrade Rodado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Pe\u00f1uela-Epalza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-6-20210207","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1359\/jbmr.2000.15.9.1645","article-title":"Corticoid osteoporosis: practical implications of recent trials.","volume":"15","author":"Sambrook","year":"2000","journal-title":"J Bone Miner Res"},{"key":"R2-6-20210207","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0889-8529(02)00064-6","article-title":"Glucocorticoid-induced osteoporosis.","volume":"32","author":"Saag","year":"2003","journal-title":"End Metab Clin N Am"},{"key":"R3-6-20210207","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00223-006-0019-1","article-title":"The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis.","volume":"79","author":"Van Staa","year":"2006","journal-title":"Calcif Tissue Int"},{"key":"R4-6-20210207","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/bmj.313.7053.344","article-title":"Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study.","volume":"313","author":"Walsh","year":"1996","journal-title":"BMJ"},{"key":"R5-6-20210207","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/ard.61.1.32","article-title":"Prevalence of long term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice.","volume":"61","author":"Gudbjornsson","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"R6-6-20210207","first-page":"2195","article-title":"Variations in physicians' judgments about corticosteroid induced osteoporosis by physician speciality.","volume":"25","author":"Buckley","year":"1998","journal-title":"J Rheumatol"},{"key":"R7-6-20210207","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1002\/art.10619","article-title":"Missed opportunities in physician management of glucocorticoid-induced osteoporosis?","volume":"42","author":"Ramsey-Goldman","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R8-6-20210207","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/archinte.161.10.1322","article-title":"Prevention of glucocorticoid-induced osteoporosis: experience in a managed care setting.","volume":"161","author":"Yood","year":"2001","journal-title":"Arch Intern Med"},{"key":"R9-6-20210207","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/1529-0131(200107)44:7<1496::AID-ART271>3.0.CO;2-5","article-title":"Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update.","volume":"44","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R10-6-20210207","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/art.10613","article-title":"Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in academic rheumatology practice.","volume":"46","author":"Solomon","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R11-6-20210207","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/rheumatology\/41.9.1021","article-title":"A regional audit of the prevention and treatment of corticosteroid-induced osteoporosis in patients with rheumatic diseases in the West Midlands.","volume":"4","author":"Erb","year":"2002","journal-title":"Rheumatology"},{"key":"R12-6-20210207","first-page":"1651","article-title":"Trends in prevention of glucocorticoid-induced osteoporosis.","volume":"33","author":"Saag","year":"2006","journal-title":"J Rheumatol"},{"key":"R13-6-20210207","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00198-003-1565-2","article-title":"An evaluation of the United Kingdom National Osteoporosis Society position statement on the use of peripheral dual-energy X-ray absorptiometry.","volume":"15","author":"Patel","year":"2004","journal-title":"Osteoporos Int"},{"key":"R14-6-20210207","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1385\/JCD:7:1:111","article-title":"Ability of peripheral DXA measurement to diagnose osteoporosis as assessed by central DXA measurement.","volume":"7","author":"Picard","year":"2004","journal-title":"J Clin Densitom"},{"key":"R15-6-20210207","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00198-005-2032-z","article-title":"Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: a consensus document of the Belgian Bone Club.","volume":"17","author":"Devogelaer","year":"2006","journal-title":"Osteoporos Int"},{"key":"R16-6-20210207","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1359\/jbmr.2003.18.5.919","article-title":"Prevention and treatment of osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium.","volume":"18","author":"Sambrook","year":"2003","journal-title":"J Bone Miner Res"},{"key":"R17-6-20210207","first-page":"132","article-title":"A cost effectiveness analysis of calcium and vitamin D supplementation, etidronate, and alendronate in the prevention of vertebral fractures in women treated with glucocorticoids.","volume":"30","author":"Buckley","year":"2003","journal-title":"J Rheumatol"},{"key":"R19-6-20210207","first-page":"1461","article-title":"Prevention of glucocorticoid induced osteoporosis. Why are we doing so poorly?","volume":"33","author":"Yood","year":"2006","journal-title":"J Rheumatol"}],"container-title":["JCR: Journal of Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00124743-200806000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T07:01:11Z","timestamp":1618038071000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00124743-200806000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/rhu.0b013e31816b1931","relation":{},"ISSN":["1076-1608"],"issn-type":[{"value":"1076-1608","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}